Pharmacogenetics and the pharmacological management of depression.

Abstract excerpt

Depression is a chronic disease seen in many healthcare settings. Current pharmacological treatment options are successful in two-thirds of patients. One CYP450 enzyme, CYP2D6, is responsible for the metabolism of 30% of all drugs including many antidepressants. Phenotypes of metabolizer status affect antidepressant treatment outcomes and adverse drug reactions.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adolescent
• Share to Antidepressive Agents
• Share to Child